We investigated the effect of α-adrenergic and cholinergic receptor agonists on Ca2 current in adult rat trigeminal ganglion neurons using whole-cell patch clamp methods. The application of acetylcholine, carbachol, and oxotremorine (50 ㄍM each) produced a rapid and reversible reduction of the Ca2 current by 17⁑6%, 19⁑3%, and 18⁑4%, respectively. Atropine, a muscarinic antagonist, blocked carbachol- induced Ca2 current inhibition to 3⁑1%. Norepinephrine (50 ㄍM) reduced Ca2 current by 18⁑2%, while clonidine (50 ㄍM), an α2-adrenergic receptor agonist, inhibited Ca2 current by only 4⁑1%. Yohimbine, an α2-adrenergic receptor antagonist, did not block the inhibitory effect of norepinephrine on Ca2 current, whereas prazosin, an α1-adrenergic receptor antagonist, attenuated the inhibitory effect of norepinephrine on Ca2 current to 6⁑1%. This pharmacology contrasts with α2-adrenergic receptor modulation of Ca2 channels in rat sympathetic neurons, which is sensitive to clonidine and blocked by yohimbine. Our data suggest that the modulation of voltage dependent Ca2 channel by norepinephrine is mediated via an α1-adrenergic receptor. Pretreatment with pertussis toxin (250 ng/ml) for 16 h greatly reduced norepinephrine- and carbachol-induced Ca2 current inhibition from 17⁑3% and 18⁑3% to 2⁑1% and 2⁑1%, respectively. These results demonstrate that norepinephrine, through an α1-adrenergic receptor, and carbachol, through a muscarinic receptor, inhibit Ca2 currents in adult rat trigeminal ganglion neurons via pertussis toxin sensitive GTP-binding proteins.